Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2011
03/30/2011EP2300459A1 Novel phenylpyrazinones as kinase inhibitors
03/30/2011EP2300458A1 Substituted 1-(diazinyl) pyrazole-4-yl-acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
03/30/2011EP2300457A1 Substituted pyrroles and methods of use
03/30/2011EP2300456A1 Bicyclic compounds having activity at the cxcr4 receptor
03/30/2011EP2300455A2 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl) - imidazo [1, 2-b] [1, 2, 4] triazin-2-yl] benzamide and processes related to preparing the same
03/30/2011EP2300454A1 Novel Microbiocides
03/30/2011EP2300453A1 3, 4 - substituted piperidine derivatives as renin inhibitors
03/30/2011EP2300452A1 5-ý5-ý2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoylmethylamino¨-4-(4-fluoro-2-methylphenyl)¨-2-pyridinyl-2-alkyl-prolinamide as nk1 receptor antagonists
03/30/2011EP2300443A1 Triazole derivatives useful for the treatment of diseases
03/30/2011EP2300440A1 3,4-dihydropyrimidine trpa1 antagonists
03/30/2011EP2300438A1 Imidazole derivatives useful as inhibitors of faah
03/30/2011EP2300435A2 Heterocyclic compounds as factor ixa inhibitors
03/30/2011EP2300430A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
03/30/2011EP2300428A1 Aminopyridine derivatives
03/30/2011EP2300427A1 Urea compounds as gamma secretase modulators
03/30/2011EP2300422A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
03/30/2011EP2300005A1 Small molecule inhibitors of botulinum neurotoxins
03/30/2011EP2299824A1 Pyrazole derivatives useful as inhibitors of faah
03/30/2011EP1924577B1 Substituted benzimidazoles and methods of preparation
03/30/2011EP1838674B1 Heteroaryl sulfonamides and ccr2
03/30/2011EP1441719B1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors
03/30/2011EP1277738B1 Condensed heteroaryl derivatives
03/30/2011CN1966500B Quinoxaline derivative, preparation method and uses
03/30/2011CN1898210B 2-pyridinylethylcarboxamide derivatives and their use as fungicides
03/30/2011CN1876664B Organometallic complex and organic electroluminescent device using the same
03/30/2011CN101998951A Acylthiourea compound or salt thereof, and use thereof
03/30/2011CN101993431A Method for synthesizing trifloxysulfuron
03/30/2011CN101993416A Quinoline compound and preparation method thereof, medicament combination containing compound and application of compound
03/30/2011CN101993415A Compound as Hedgehog path inhibitor, medicine composition containing same and application thereof
03/30/2011CN101993409A Heterocyclic compound, organic light-emitting device containing polycyclic heteroaryl compounds
03/30/2011CN101445483B Method for preparing pesticide
03/30/2011CN101402598B Improved method for preparing 1-benzhydryl-3-aza ring butanol
03/30/2011CN101133049B Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol
03/30/2011CN101133027B Pyridine-2-carboxamide derivatives as mglur5 antagonists
03/30/2011CN101121692B Synthesis method for alpha-carbonylamide compound
03/29/2011US7915423 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
03/29/2011US7915422 enantioselective catalytic oxidation of a prochiral sulfide for making esomeprazole, omeprazole or optically active salt form nexium, in presence of a chiral transition metal complex and solvent-free; proton pump inhibitors useful in the treatment of ulcers
03/29/2011US7915294 Method of treating colorectal carcinoma
03/29/2011US7915293 Carbocyclic and heterocyclic sulfonamide derivatives, e.g., N-(2-bromo-5-(trifluoromethoxy)phenyl)-3,5-dichloro-4-(2-chloro-4-nitrophenoxy)benzenesulfonamide and 4-(2-(trifluoromethyl)phenoxy)-1-(3-trifluoromethyl)phenylsulfonyl)piperidine; treating proliferative diseases
03/29/2011US7915291 Hepatitis C virus inhibitors
03/29/2011US7915288 1-aryl-4-substituted isoquinolines
03/29/2011US7915287 Substituted heterocycles and methods of use
03/29/2011US7915283 e.g. 1-[4-(1-Phenyl-1-(pyrazinyl)-methylene)-piperidin-1-yl]-2-(4-methoxy-7-pyrazinyl-6-azaindol-3-yl)-ethane-1,2-dione; viricides for prophylaxis of lympadenopathy associated virus; synergystic mixtures with immunomodulators
03/29/2011US7915274 Nitrogen containing heterocyclic compounds and medicines containing the same
03/29/2011US7915263 Aminopyridine derivatives having aurora A selective inhibitory action
03/29/2011US7915261 Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound
03/29/2011US7915260 Urotensin II receptor antagonists
03/29/2011US7915253 4-[2,6-Dimethyl-4-(4-trifluoromethoxy-phenyl)-piperazine-1-sulfonyl]-indan-2-carboxylic acid; peroxisome proliferator activated receptors modulator; antidiabetic, antiinflammatory agent; obesity, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome, ischemia-associated organ injury
03/29/2011US7915251 Alpha-helix mimetics and methods relating to the treatment of fibrosis
03/29/2011US7914706 Charge transport compositions and electronic devices made with such compositions
03/29/2011CA2543250C Process for the preparation of ccr-2 antagonist
03/29/2011CA2497237C N-substituted-2-oxodihydropyridine derivatives
03/29/2011CA2489276C Tricyclic steroid hormone nuclear receptor modulators
03/29/2011CA2469055C Aminotetralin derivatives as muscarinic receptor antagonists
03/29/2011CA2468715C Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
03/29/2011CA2443672C Aryl and biaryl piperidines used as mch antagonists
03/29/2011CA2400856C Imaging agents for diagnosis of parkinson's disease
03/29/2011CA2299139C 4-phenyl-pyridine derivatives
03/24/2011WO2011035332A1 Pyrrolidinone carboxamide derivatives as chemerin-r ( chemr23 ) modulators
03/24/2011WO2011035110A2 Treatment for oxidative stress and/or hypertension
03/24/2011WO2011034518A1 Hcv protease inhibitors
03/24/2011WO2011034504A1 Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and methods of making the same
03/24/2011WO2011034078A1 Glycine compound
03/24/2011WO2011033531A1 A reusable end-capped bipyridine compound useful for selective detection of cyanide anions and process for preparation thereof
03/24/2011WO2011033468A1 Process for the preparation of a crystalline form of lenalidomid
03/24/2011WO2011033307A1 Nilotinib dihydrochloride salt
03/24/2011WO2011033099A1 Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia
03/24/2011WO2011033045A1 Heterocyclic antiviral compounds
03/24/2011WO2011033018A1 Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines
03/24/2011WO2011032692A1 Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazol[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
03/24/2011WO2011032474A1 Method for preparing halofuginone derivative
03/24/2011WO2011032320A1 Novel alkene oxindole derivatives
03/24/2011WO2011032291A1 Selective calcium channel modulators
03/24/2011WO2011032277A1 Quinazolinone derivatives as viral polymerase inhibitors
03/24/2011US20110071298 Processes and Intermediates
03/24/2011US20110071291 Hydrazide compound and pesticidal use of the same
03/24/2011US20110071289 Aminopyrazole amide derivative
03/24/2011US20110071286 Novel preparation process
03/24/2011US20110071195 Novel alkene oxindole derivatives
03/24/2011US20110071194 Chemical Compounds 572
03/24/2011US20110071192 Therapeutic Agents Useful for Treating Pain
03/24/2011US20110071191 Insecticidal compounds
03/24/2011US20110071190 Biphenyl compounds useful as muscarinic receptor antagonists
03/24/2011US20110071165 Aza- and polyazanthranyl amides and their use as medicaments
03/24/2011US20110071159 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament
03/24/2011US20110071158 New compounds
03/24/2011US20110071156 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
03/24/2011US20110071153 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors
03/24/2011US20110071152 5-membered heterocycle-based p38 kinase inhibitors
03/24/2011US20110071150 Indole derivatives as crac modulators
03/24/2011US20110071149 Selective kinase inhibitors
03/24/2011US20110071148 Compounds as the estrogen related receptors modulators and the uses thereof
03/24/2011US20110071145 Raf Modulators And Methods Of Use
03/24/2011US20110071144 Quinazoline derivatives and pharmaceutical compositions containing them
03/24/2011US20110071134 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
03/24/2011US20110071132 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof
03/24/2011US20110071131 Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands
03/24/2011US20110071130 2-aminobenzimidazoles for treating neurodegenerative diseases
03/24/2011US20110071126 Inhibitors of beta-secretase
03/24/2011US20110071113 Thiazole Derivatives and Use Thereof